Meeting Agenda

Agenda

8:30-8:45 Introduction

8:45-9:00 Clinical Description and Diagnosis of Multiple Sclerosis

Emmanuelle Waubant, MD, University of California, San Francisco Multiple
Sclerosis Center (co-author of commissioned paper posted on IOM website)

Epidemiological studies

9:00-9:30 Pharmacovigilance and Case-Control Study of Hepatitis B
Vaccine and Multiple Sclerosis

Bernard Begaud (Presenting via conference call)
Annie Fourrier (Presenting via conference call)
Universite Victor Segalen Bordeaux, France

9:30-10:15 Risk of MS Relapse after Immunization: European Database for
Multiple Sclerosis

Samy Suissa, PhD, McGill University

10:15-10:30 Break

10:30-11:15 Risk of MS after Hepatitis B Immunization: The Nurses'
Health Study

Alberto Ascherio, MD, DrPH, Harvard University

11:15-12:00 Risk of Demyelinating Disease after Hepatitis B
Vaccination: the Vaccine Safety Datalink

Frank DeStefano, MD, MPH, Centers for Disease Control and Prevention

12:00-1:00 Lunch

1:00-1:45 Possible Mechanisms for Hepatitis B Vaccine-induced Multiple
Sclerosis and Other Demyelinating Diseases
Emmanuelle Waubant, MD, University of California, San Francisco Multiple
Sclerosis Center
(co-author of commissioned paper posted on IOM website)

1:45-2:30 Recommendations for Newborn and Infant Hepatitis B Vaccination
Historical Perspective: Neal Halsey, MD
Johns Hopkins University

Recent Analyses of Hepatitis B Viral Infections in Children
Eric Mast, MD
National Center for Infectious Diseases, CDC

2:30-3:15 Update on Communications Activities, National Immunization
Program, Centers for Disease Control and Prevention
Glen Nowak, PhD

3:15-4:00pm Public Comment Session and Discussion

Back to Meeting